Asthma presented substantial global burden, affecting 358.2 million people in 2015. A complex disease, it impairs the social, physical and psychological well-being of the affected. Furthermore, the asthmatic condition can be differentiated into controlled, partially controlled and uncontrolled. The differentiation finds its basis in the level of severity of clinical manifestations (Koshak, 2007). With respect to which the Global asthma report 2014 mentions the higher economic burden associated with the uncontrolled condition (The Global Asthma Network, 2014). Besides the level of manifestation, the level of development also finds an association with disease economic burden. In an attempt to bring out the economic burden borne by developing and developed regions, the discussion presents the case of USA and India. Read more »
Allergic asthma a well-known chronic disease, of heterogeneous nature, affects respiratory airways. It presents several phenotypes on the basis of the disease progress. These phenotypes form recognizable demographic and clinical clusters around the globe. These phenotypes include allergic asthma, non-allergic asthma, late-onset asthma, asthma with fixed airflow limitation and asthma with obesity. Amongst all the different phenotypes, allergic asthma is recognized most easily. It has become highly prevalent since the latter half of 20th century, in both developing and developed nations. Read more »
The allergic disorders present a wide array of manifestations in the humans, demanding unique therapeutic strategies. The previous article shed light on treatment strategies for lethal Anaphylaxis, allergic Rhinitis & Asthma. The ocular and skin allergies not only compromise the quality of life but also makes the patient self-conscious about appearance. Read more »
The previous articles shed light on the prevalence of allergic diseases across five different geographic locations. Thus showing allergies to be a global problem and exerts considerable socioeconomic burden on the respective nations. Allergic diseases like Anaphylaxis, Rhinitis and Asthma interfere with day to day activities of an individual, resulting in physical and emotional distress. Read more »
The discussions on allergic disorders till now emphasized on the prevalence and severity, besides highlighting the significant treatment options. Henceforth, it is essential to discuss the economics associated with the different treatment options. This demands the exploration of the cost of illness also known as the burden of disease. Read more »
Paracetamol was discovered by McNeil Laboratories in 1955 as an analgesic and antipyretic for children and is further said to be a non-opiod analgesic and is often known as acetaminophen. It is considered as a first line analgesic and is considered safe and effective in pain relieve against muscoskeletal pain caused due to rheumatoid arthritis and fever. Read more »
Penicillin was discovered by Ernest Duchesne in 1896 and Alexander Fleming by isolating the antibiotic substance from the fungus Penicillium chrysogenum. The fungus produces this antibiotic when its food resources are limited as a mechanism to kill bacteria. It is used in the treatment of a variety of infections (such as scarlet fever, skin, ear and throat infection, pneumonia, rheumatic fever, chorea). Read more »
The prevalence of different allergies has been explored in the previous articles across 5 case countries and comparisons have been drawn with prevalence in India. The findings implicate that incidence of several allergic responses have been rising continuously mainly due to development in technology and increase in severe pollution. Allergic reactions in present times are affecting nearly 20-30% of the Indian population. Allergy has become a cause of concern for both individuals and government. This is because of its social and economic impact in terms of cost of healthcare, loss of working hours and lower quality of life among others. This article explores the social and economic burden of allergic diseases in India.